Leo Pharma Sustainability Profile
Leo Pharma, officially known as Leo Pharmaceutical Products Ltd., is a global leader in dermatology and critical care, headquartered in Denmark (DK). Founded in 1908, the company has established a strong presence in Europe, North America, and Asia, focusing on innovative solutions for skin diseases and conditions. With a commitment to research and development, Leo Pharma offers a range of unique products, including topical treatments and biologics, specifically designed for conditions such as psoriasis and eczema. The company is renowned for its patient-centric approach, ensuring that its therapies are both effective and accessible. As a prominent player in the pharmaceutical industry, Leo Pharma has achieved significant milestones, including numerous partnerships and advancements in dermatological care, solidifying its position as a trusted name in the market.
DitchCarbon Score
How does Leo Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Leo Pharma's score of 75 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Leo Pharma's reported carbon emissions
In 2024, LEO Pharma A/S reported total carbon emissions of approximately 288,876,000 kg CO2e across all scopes. This includes 20,050,000 kg CO2e from Scope 1, 266,000 kg CO2e from market-based Scope 2 emissions, and a significant 288,876,000 kg CO2e from Scope 3 emissions. The combined Scope 1 and 2 emissions totalled about 22,316,000 kg CO2e. LEO Pharma has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 53% by 2030, using 2019 as the baseline year. This target is aligned with the Science Based Targets initiative (SBTi) and reflects the company's commitment to limiting global warming to 1.5°C. Additionally, LEO Pharma aims for 75% of its suppliers, based on emissions from purchased goods and services, capital goods, and upstream transportation and distribution, to have science-based targets by 2026. In previous years, LEO Pharma's emissions were as follows: in 2023, they reported approximately 28,855,800 kg CO2e from Scope 1 and 2 combined, and in 2022, the total was about 24,309,000 kg CO2e. The company has demonstrated a commitment to reducing its carbon footprint, with a target to cut emissions by more than 50% by 2030 compared to 2019 levels. Overall, LEO Pharma's climate strategy reflects a proactive approach to sustainability, with clear targets and a focus on reducing emissions across its operations and supply chain.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 12,395,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 10,100 | 00,000 | 00,000 | 00,000 | 00,000,000 | 0,000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | 388,000 | 000,000 | 000,000 | 000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Leo Pharma's Industry?
How Carbon Intensive is Leo Pharma's Location?
Leo Pharma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Leo Pharma has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Jamjoom Pharmaceuticals Factory Company
Frequently Asked Questions
Common questions about Leo Pharma's sustainability data and climate commitments